2012 ACR/ARHP Annual Meeting Archives - Page 55 of 180

Abstract Number: 911

Race- and Sex-Specific Estimates of 10-, 20-, 30-Year, and Lifetime Risk of Diagnosed Symptomatic Knee Osteoarthritis and the Need for TKR in the US
Abstract Number: 908

Race, Gender and Total Knee Replacement Consideration: The Role of Social Support
Abstract Number: 2138

Racial and Ethnic Disparities in Rheumatoid Arthritis Outcomes in Community-Based U.S. Rheumatology Practices: Results From the Consortium of Rheumatology Researchers of North America Registry
Abstract Number: 795

Racial Differences in Pain Coping Efficacy in Patients with Hip and Knee Osteoarthritis
Abstract Number: 744

Racial Differences in Reported Knee Pain Severity Persist Even After Adjustment for Knee Examination and Radiographic Findings: Data From the Osteoarthritis Initiative
Abstract Number: 2514

Racial/Ethnic Trends in Incidence and Prevalence of Rheumatoid Arthritis in a Large Multi-Ethnic Managed Care Population
Abstract Number: 572

Radiographic Damage in Ankylosing Spondylitis Over 12 Years of Follow-up: A Longitudinal Analysis
Abstract Number: 1012

Radiographic Deformity of the Foot Is Starting From the Early Stage of Rheumatoid Arthritis
Abstract Number: 2631

Radiographic Osteoarthritis Severity Is Associated with an Increased Risk of Developing Knee Pain: Findings From the Osteoarthritis Initiative
Abstract Number: 2486

Radiographic, Clinical and Functional Comparison of Tofacitinib Monotherapy Versus Methotrexate in Methotrexate-Naïve Patients with Rheumatoid Arthritis
Abstract Number: 1110

Radiologic Progression in Hand Osteoarthritis (OA) Over 2.6 Years – Data From the Sekoia Trial
Abstract Number: 2007

Radiological Peripheral Involvement At Hands, Feet and Hips in Young Adults with Polyarticular Idiopathic Juvenile Arthritis
Abstract Number: 2002

Randomized Clinical Trial in Pediatric Rheumatology: Are Parents and Patients in Equipoise?
Abstract Number: 570

Randomized Controlled Trial of Adalimumab in Patients with Peripheral Spondyloarthritis
Abstract Number: 2648

Randomized Placebo-Controlled Trial of Local Steroid Injection for Moderately Severe Carpal Tunnel Syndrome
Abstract Number: 2620

Randomized, Double-Blind, Placebo-Controlled Studies of P140 Peptide in Mannitol (Lupuzor) and Trehalose (Forigerimod) in Patients with SLE
Abstract Number: 2655

Rapid and Effective Response to Immunosuppression in Treating Macrophage Activation Syndrome Associated with a Heterozygous Dominant Negative Mutation in RAB27a Leading to Decreased Cytolytic Activity
Abstract Number: 558

Rapid Improvements in Patient Reported Outcomes with Certolizumab Pegol in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 24 Week Results of a Phase 3 Double Blind Randomized Placebo-Controlled Study
Abstract Number: 2642

Rate and Predictors of Work Disability in Fibromyalgia
Abstract Number: 2093

Rates of Opportunistic Infections Among Rheumatoid Arthritis Patients Switching Biologic Therapy
Abstract Number: 1215

Rates of Orthopaedic Interventions for Rheumatoid Arthritis Have Changed Over the Last 25 Years. A Report From Two UK Inception Cohorts Reflecting Treatment Changes From Sequential DMARD Monotherapy to Anti-TNF Agents (1986-2011)
Abstract Number: 2094

Reactivation of Hepatitis B Virus in Autoimmune Disease Patients Receiving Immunosuppressive Agents
Abstract Number: 2441

Readability and Suitability Assessment of Patient Education Materials in Rheumatic Diseases
Abstract Number: 1405

Real World Experience Comparing Multiplex Immunobead Assay versus Immunoflorescence Assay for Anti-Nuclear Antibody Detection At a University Hospital
Abstract Number: 2246

Real World Experience with Belimumab in the Management of Systemic Lupus Erythematosus (SLE): A Single Center, Observational, Post-Marketing Study
Abstract Number: 496

Real-World Effectiveness of Infliximab in Improving Routine Assessment of Patient Index Data 3 Outcomes: The Canadian Experience
Abstract Number: 460

Real-World Efficacy and Safety of Abatacept Treatment for Rheumatoid Arthritis: 12-Month Interim Analysis of the Action Study
Abstract Number: 1159

Reasons and Predictors of Methotrexate Discontinuation in Children with JIA: Results From the Childhood Arthritis Prospective Study (CAPS)
Abstract Number: 34

Rebamipide Attenuates Pain Severity and Cartilage Degeneration in a Rat Model of Osteoarthritis by Downregulating Oxidative Damage and Catabolic Activity in Chondrocytes
Abstract Number: 884

Receptor Activator of Nuclear Factor ÊB Ligand-Mediated Osteoclastogenesis Is Augmented by Interleukin-1â Via up-Regulation of Endoplasmic Reticulum Stress Signals
Abstract Number: 1770

Recognition of Citrullinated and Carbamylated Proteins by Human Antibodies: Specificity, Cross-Reactivity and the “AMC-Senshu” Method
Abstract Number: 2015

Recognizing Two Distinct Clinical Phenotypes in Muckle-Wells Syndrome
Abstract Number: 535

Reduced Joint Counts Misclassify Psoriatic Arthritis Patients with Oligoarthritis and Miss Significant Active Disease
Abstract Number: 2318

Reduced Thymus Function and Accelerated T-Cell Aging in Patients with Axial Spondylarthritis
Abstract Number: 265

Reducing Loads in the Contralateral Side in Medial Knee Osteoarthritis; A 3-Year Follow-up Study
Abstract Number: 299

Reduction of Cerebral and Corpus Callosum Volumes in Childhood-Onset Systemic Lupus Erythematosus. A Volumetric Magnetic Resonance Imaging Analysis
Abstract Number: 350

Reduction of Inflammation with Abatacept and Tocilizumab Results in Lower N-Terminal Pro Brain Natriuretic Peptide Levels in Patients with Rheumatoid Arthritis: Results From Prospective Cohort Studies
Abstract Number: 576

Reference Intervals of Spinal Mobility Measures in Normal Individuals – the Mobility Study
Abstract Number: 2208

Referral Patterns and Diagnosis of Patients with Axial Spondyloarthritis: Results of an International Survey
Abstract Number: 1399

Regional Fat Distribution Is Independently Associated with Damage Accrual in Systemic Lupus Erythematosus Female Patients
Abstract Number: 2064

Regular Measure of Disease Activity During the Routine Care of Rheumatoid Arthritis Patients Involves Some Extra Work but Positive Results
Abstract Number: 2154

Regulation of Folate Pathway Related Genes in Methotrexate naïve and Methotrexate Treated Patients with Rheumatoid Arthritis
Abstract Number: 1910

Regulation of Microrna 223 Expression in a Gouty Arthritis
Abstract Number: 513

Regulatory B Cells in Primary Sjögren’s Syndrome
Abstract Number: 1744

Regulatory B Cells Supress the Progression of Fatal Autoimmunity in Lupus-Prone Mice
Abstract Number: 2087

Regulatory Effect of the Combination of Methotrexate and 1,25-Dihydroxyvitamin D3 On the Balance of Treg and Th17 in Collagen-Induced Arthritis
Abstract Number: 1185

Regulatory Role of 1, 25 Dihydroxyvitamin D3 in the Pathogenesis of Autoimmune Arthritis
Abstract Number: 1919

Regulatory T Cells in IgG4-Related Disease Patients Presenting with Sclerosing Sialadenitis and Dacryoadenitis
Abstract Number: 600

Regulatory T Cells in Spondyloarthritis (SpA) Animal Model and Modulatory Role of Inducible Costimulator (ICOS)
Abstract Number: 2357

Relapses in Patients with Giant-Cell Arteritis: Prevalence, Characteristics and Associated Clinical Findings in a Prospectively Followed Cohort of 106 Patients
Abstract Number: 1115

Relation Between Hip Dysplasia, Pain, and Osteoarthritis in a Cohort of Patients with Hip Symptoms
Abstract Number: 1977

Relationship Between Baseline Bone Turnover Marker Levels and Bone Mineral Density Changes in Men with Low Bone Mineral Density Receiving Denosumab or Placebo
Abstract Number: 1998

Relationship Between Changes in Bone Mineral Density and Incidence of Fracture with 6 Years of Denosumab Treatment
Abstract Number: 2133

Relationship Between Clinical Response and Radiographic Outcomes in Patients with Moderate Rheumatoid Arthritis
Abstract Number: 1410

Relationship Between Individual Organ Damage and Mortality of Systemic Lupus Erythematosus (SLE): A Prospective Cohort Study of 679 Patients
Abstract Number: 1274

Relationship Between Morning Stiffness Duration and Severity, Pain Intensity, and Measures of Disease Activity in a 12 Week Efficacy Study of a Modified (Delayed-Release) Prednisone Plus Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
Abstract Number: 1816

Relationship Between Race, Uric Acid Levels, Urate-Lowering Therapy and Resource Use in Patients with Gout
Abstract Number: 1703

Relationship Between Tobacco Smoking and Radiographic Spinal Progression in Axial Spondyloarthritis: The Role of Inflammatory Activity
Abstract Number: 242

Relationship of Objective to Self-Reported Physical Activity Measures Among Adults in the Osteoarthritis Initiative
Abstract Number: 243

Relationship of Physical Activity with Health Utility in the Osteoarthritis Initiative
Abstract Number: 1588

Relationship Over Time Between Beliefs, Motivation, and Worries about Physical Activity and Physical Activity Participation in Persons with Knee Osteoarthritis
Abstract Number: 72

Relationships Between Air Pollution and Presence of Rheumatoid Arthritis-Related Autoantibodies in Individuals without Rheumatoid Arthritis: Studies of the Etiology of Rheumatoid Arthritis
Abstract Number: 585

Relative Overexpression of Membrane-Bound Versus Soluble TNF in Human and Experimental Spondyloarthritis
Abstract Number: 170

Relative Risk of Infusion Reactions with KRYSTEXXA® (pegloticase) From Post-Approval Safety Data: Results From Sept 2010 to June 2012
Abstract Number: 2100

Relative, Reliability-Adjusted Diagnostic Test Accuracy of Erosion Detection Between Magnetic Resonance Imaging and Radiography in Rheumatoid Arthritis
Abstract Number: 1033

Reliability and Responsiveness of Two Methods for Assessment of Magnetic Resonance Imaging Abnormalities in Hip Osteoarthritis in a Placebo-Controlled Trial of Intra-Articular Steroid Injection
Abstract Number: 124

Reliability of an Ultrasound Scoring Measure for Juvenile Localized Scleroderma (jLS)
Abstract Number: 2103

Reliability of DAS28 in Rheumatoid Arthritis When Based On Patient Self-Assessment of Tender and Swollen Joints
Abstract Number: 2029

Reliability of Scoring a Disease Damage Measure for Juvenile Localized Scleroderma
Abstract Number: 1018

Reliability of the Early Erosions in Rheumatoid Arthritis Software When Quantifying Bone Loss
Abstract Number: 394

Remission After One Year in ACPA Positive and ACPA Negative Patients with Early Arthritis
Abstract Number: 1335

Remission Induction in Early Active Rheumatoid Arthritis: Comparison of Tocilizumab Versus Methotrexate Monotherapy
Abstract Number: 404

Remission is a Difficult Target in Clinical Practice When RA Disease Is Established
Abstract Number: 773

Remission Rates with Tofacitinib Treatment in Rheumatoid Arthritis: A Comparison of Various Remission Criteria
Abstract Number: 723

Renal Dysfunction and Disease Severity in Scleroderma-Associated Pulmonary Arterial Hypertension
Abstract Number: 318

Replication Analysis of Non-HLA Gene Variants with Prior Evidence of Association with Juvenile Idiopathic Arthritis
Abstract Number: 1863

Resetting the Naming Speed Clock with Methylphenidate (Ritalin)
Abstract Number: 785

Resident Lung Fibroblast Gene Expression Signatures Predict Susceptibility or Resistance to Experimental Lung Fibrosis
Abstract Number: 2639

Residual Disease Activity in Patients with Early Rheumatoid Arthritis Who Were Classified As Being in Remission According to 8 Different Descriptions: Post Hoc Analysis of the Etude Et Suivi Des Polyarthrites Indifférenciées Récentes (ESPOIR) Cohort
Abstract Number: 1586

Resistance Exercise Training for Fibromyalgia: A Systematic Review
Abstract Number: 1971

Resolution of Effects On Bone Turnover Markers and Bone Mineral Density After Discontinuation of Long-Term Bisphosphonate Use
Abstract Number: 2560

Response and Drug Survival of 1^st TNF-Inhibitor in 440 Patients with Psoriatic Arthritis – What Is the Role of Co-Medication with Methotrexate?
Abstract Number: 1140

Response to Adalimumab in 40 Patients with refractory juvenile Idiopathic Arthritis-Associated Uveitis. A Multicenter Study
Abstract Number: 362

Response to Etanercept, but Not Infliximab or Adalimumab, Is Inversely Associated with Body Mass Index
Abstract Number: 2125

Response to Methotrexate Plus Prednisone in Camera II Using a Multi-Biomarker Disease Activity (Vectra^TMDA) Test and DAS28-ESR
Abstract Number: 837

Response to MMF Therapy for Lupus Nephritis Is Independent of Genetic Variation of Inosine Monophosphate Dehydrogenase
Abstract Number: 2444

Restricting Back Pain Is Associated with Disability in Community-Living Older Persons
Abstract Number: 717

Results From a Multi-Tiered Item Collection On Linking Systemic Sclerosis to the International Classification of Functioning, Disability and Health: A EULAR Scleroderma Trials and Research Initiative
Abstract Number: 2032

Results From a Multicentre International Registry of Familial Mediterranean Fever: Impact of Genetic and Environment Factors On the Expression of a Monogenic Disease in Children
Abstract Number: 2555

Results of the Beliss Study, the First Open Phase 2 Study of Belimumab in Primary Sjogren’s Syndrome
Abstract Number: 2157

Resveratrol Counters Pro-Atherogenic Effects of Systemic Lupus Erythematosus and Rheumatoid Arthritis Plasma On Cholesterol Efflux in Human Macrophages
Abstract Number: 388

Retention Rate of the Anti-TNF Biologics in the Treatment of Rheumatic Diseases and Predictive Factors for Drug Withdrawal: Data From the Hong Kong Biologics Registry
Abstract Number: 636

Retrospective Study of Allogenic Mesenchymal Stem Cells Transplantation in Active and Refractory Lupus Nephritis for Induction Therapy
Abstract Number: 200

Rheumatic Manifestations and Connective Tissue Diseases in Autoimmune Hepatitis of the Child and the Adult
Abstract Number: 1272

Rheumatoid Arthritis (RA) Incomplete Secondary Responders to TNF-Alpha Safely Achieve Efficacy by Switching to Certolizumab Pegol in a 24-Week Study: A Phase IV, Randomized Multicenter, Double-Blind, Twelve-Week Study Followed by a 12 -Week Open-Label Phase
Abstract Number: 2127

Rheumatoid Arthritis (RA) Patients Discordant for Rheumatoid Factor and Anti-CCP Positivity Have Different Clinical and Laboratory Features Than RA Patients Seropositive or Seronegative for Both Markers
Abstract Number: 2630

Rheumatoid Arthritis and Osteoarthritis in the Population: How Different Is the Impact?
Abstract Number: 1229

Rheumatoid Arthritis and Risks of Malignant Lymphoma – Are Risks Still Increased?
Abstract Number: 1287

Rheumatoid Arthritis Comparison of Active Therapies in Methotrexate Suboptimal Responders: Validation of the Strategy of Conventional Disease Modifying Anti-Rheumatic Drugs Before Biologicals
Abstract Number: 1224

Rheumatoid Arthritis Disease Activity During Pregnancy Affects the Postnatal Catch-up Growth of the Child
Abstract Number: 2479

Rheumatoid Arthritis Does Not Increase Risk of Short Term Total Knee Replacement (TKR) Adverse Events (AE)
Abstract Number: 1231

Rheumatoid Arthritis Is Associated with Likelihood of Being Overweight in Women
Abstract Number: 1765

Rheumatoid Arthritis Is Associated with Signaling Alterations in Naturally Occurring Autoreactive B-Lymphocytes
Abstract Number: 1262

Rheumatoid Arthritis Patients with Higher Disease Severity and Subclinical Carotid Plaque Experience More Cardiovascular Events Despite a Favorable Conventional Cadiovascular Risk Profiles
Abstract Number: 1853

Rheumatoid Arthritis Patients’ Experiences of Medication Side Effects and Subsequent Decision Making about Medications
Abstract Number: 1227

Rheumatoid Arthritis-Associated Interstitial LUNG Disease: Clinical Spectrum of A Large Cohort From A Respiratory Referral Center
Abstract Number: 2452

Rheumatoid Arthritis-Associated PTPN22 Modulates Toll-Like Receptor-Mediated, Type 1 Interferon-Dependent Innate Immunoregulation
Abstract Number: 421

Rheumatoid Factor, Not Antibodies to Citrullinated Proteins, Are Associated with High Disease Activity
Abstract Number: 1885

Rheumatologists’ Ultrasound Confidence and Interpretation of Normal Anatomy Are Improved by a Cadaver Based Sonoanatomy Course
Abstract Number: 1546

Rhinosinusits and Nasal Polyps in the Diagnosis and Follow up of Patients with Eosinophilic Granulomatosis with Polyangitis (ex-Churg Strauss Syndrome)
Abstract Number: 1729

Ribophorin II Is Involved in the Tissue Factor Expression Mediated by Phosphatidylserine-Dependent Antiprothrombin Antibody On Monocytes
Abstract Number: 813

Rilonacept for Gout Flare Prophylaxis in Patients with Chronic Kidney Disease: Analysis of 3 Clinical Trials
Abstract Number: 152

Rilonacept for Gout Flare Reduction: Estimation of Number Needed to Treat to Benefit (NNTB)
Abstract Number: 606

Risk Factors Associated with Cervical Human Papillomavirus Infection in Women with Systemic Lupus Erythematosus: The Role of Rituximab
Abstract Number: 630

Risk Factors Associated with Early Central Nervous System Damage Detected Through Diffusion Tensor Imaging (DTI) in Patients with Systemic Lupus Erythematosus
Abstract Number: 1397

Risk Factors Associated with Early Central Nervous System Damage Detected Through Perfusion MRI in Patients with Systemic Lupus Erythematosus
Abstract Number: 696

Risk Factors for EARLY Mortality in Scleroderma Patients: A Report From the EULAR Scleroderma Trials and Research Group (EUSTAR) Database
Abstract Number: 307

Risk Factors for Poor Outcomes in Hospitalized Patients with Pediatric Systemic Lupus Erythematosus
Abstract Number: 363

Risk Factors for Radiographic Progression During TNF-Inhibitor Treatment in 932 Rheumatoid Arthritis Patients Treated in Clinical Practice: Results From the Nationwide Danish Danbio Registry
Abstract Number: 1163

Risk Factors for Radiologic Progression in Polyarticular Juvenile Idiopathic Arthritis Patients Treated with Biologic Agents
Abstract Number: 2258

Risk Factors for Total Joint Replacement in Systemic Lupus Erythematosus Patients with Avascular Necrosis
Abstract Number: 1989

Risk Factors for Vertebral Fractures in Patients with Rheumatoid Arthritis – the Tomorrow Study –
Abstract Number: 707

Risk of Cancer in Systemic Sclerosis: Meta-Analysis of Population-Based Cohort Studies
Abstract Number: 1990

Risk of Falling Is Equivalent Between Patients with Rheumatoid Arthritis and Healthy Individuals – the Tomorrow Study-
Abstract Number: 922

Risk of Fracture Among Treated and Untreated Men with Osteoporosis
Abstract Number: 2147

Risks to Visit Emergency Room in Patients with Rheumatoid Arthritis: A Two-Year Retrospective Study
Abstract Number: 449

Rituximab After First Anti Tumor Necrosis Factor Failure Is More Efficient with High Impact in Reducing Time and Costs to Achieve Superior Rates of Low Disease Activity and Remission
Abstract Number: 2383

Rituximab As Induction and Maintenance Therapies for ANCA-Associated Vasculitis: A Multicenter Retrospective Study On 80 Patients
Abstract Number: 1543

Rituximab for ANCA-Associated Vasculitis: A Meta-Analysis of Randomized Trials
Abstract Number: 285

Rituximab for Severe Disease Flares in Childhood ANCA Vasculitides
Abstract Number: 464

Rituximab for Treatment of Rheumatoid Arthritis: Treatment Effectiveness in the Corrona Database
Abstract Number: 2596

Rituximab Treatment for Antineutrophil Cytoplasmic Antibody – Associated Vasculitis in Children
Abstract Number: 1299

Rituximab Versus Abatacept in Rheumatoid Arthritis Patients with an Inadequate Response to Prior Biologic Therapy: A Retrospective, Single-Center Study
Abstract Number: 1652

Rituximab Versus Azathioprine for Maintenance in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
Abstract Number: 524

RNA-Sequencing Identifies Novel Differentially Expressed Coding and Non-Coding Transcripts in Sjögren’s Syndrome
Abstract Number: 1520

Role of 12/15-Lipoxygenase(LOX) in Patients with Systemic Sclerosis
Abstract Number: 2307

Role of Endosomal and Cell Membrane Toll-Like Receptors in Keratinocyte Activation by Systemic Sclerosis Autoantibodies
Abstract Number: 36

Role of FK506 Binding Protein 5 in Osteoclast Differentiation
Abstract Number: 1601

Role of Focal Adhesion Kinase in Synovial Fibroblast Invasion and Arthritis
Abstract Number: 61

Role of Health Literacy in Population Estimates of Musculoskeletal Disorders
Abstract Number: 1270

Role of Inflammation, Serologic Status and Low Density Lipoprotein in Coronary Heart Disease Among Patients with Rheumatoid Arthritis: Data From the National Veterans Health Administration
Abstract Number: 28

Role of Microrna 455 Networks in Mesenchymal Cell Differentiation and Osteoarthritis
Abstract Number: 1003

Role of Particular Class I MHC Haplotypes in Determining Different Traits within the Psoriatic Arthritis Phenotypes
Abstract Number: 883

Role of Phospholipase D1 (PLD1) in the Expression of Proinflammatory Genes in Rheumatoid Arthritis Synovial Fibroblasts (RASF)
Abstract Number: 42

Role of Stromal Cell-Derived Factor-1 Alpha Through Smad and MAPK Pathway On Endochondral Ossification
Abstract Number: 2476

Role of Whole-Body Magnetic Resonance Imaging in the Assessment of Disease Activity in Juvenile Dermatomyositis. A Pilot Study.
Abstract Number: 1964

Rolofylline, an Adenosine A1R Antagonist, Acts As an Inverse Agonist to Inhibit Osteoclast Differentiation
Abstract Number: 246

Routine Assessment of Patient Index Data 3 (RAPID3) Is a Valid Index for Routine Care in Patients with Osteoarthritis
Abstract Number: 713

Rpp25 Is a Major Target of Autoantibodies to the Th/to Complex As Measured by ELISA and a New Chemilumiscence Assay